International Cancer Research Partnership |

Front Page

Read more about Front Page

ICRP Partner Meeting - March 2023

Read more about ICRP Partner Meeting - March 2023

March 16, 2023 7:00 AM (EDT) - March 16, 2023 8:00 AM (EDT)

Virtual

Meeting papers are in the ICRP March 2023 folder here

Webex links:

ICRP March 2023 Partner Meeting

https://icrp.webex.com/icrp/j.php?MTID=m3562c2318d7e6bddd5b4bf221ede490f
Thursday, March 16, 2023 11:00 AM | 1 hour | (UTC+00:00) Dublin, Edinburgh, Lisbon, London
Meeting number: 2401 699 8887
Password: 4321 (4321 from video systems)

Join by video system
Dial 24016998887@icrp.webex.com
You can also dial 62.109.219.4 and enter your meeting number.

Join by phone
Global toll-free numbers

Access code: 240 169 98887

Annual Meetings

ICRP Partner Meeting - January 2023

Read more about ICRP Partner Meeting - January 2023

January 19, 2023 11:00 AM (EST) - January 19, 2023 12:00 PM (EST)

Webex

The Agenda and papers for the January meeting are now included in the partner site folder. This month we have a presentation from Timothy Hsiao (ASTRO) on “Collaborative Innovation Programs for Radiation Oncology Research” and updates on the various workstreams, including a first analysis of metastatic breast cancer research. We’ll also continue with the breakout sessions to share information more informally and enable partners to get to know each other.

Information on how to join the call is included below.

ICRP January 2023 Partner Meeting

https://icrp.webex.com/icrp/j.php?MTID=m0760e3a911c89b753ad0e775f7c090c9

Thursday, Jan 19, 2023 11:00 am | 1 hour | (US Eastern Time)

Meeting number: 2399 718 8700

Password: 4321 (4321 from video systems)

Join by video system

Dial 23997188700@icrp.webex.com

You can also dial 62.109.219.4 and enter your meeting number.

Join by phone

Global Call-in Numbers (Toll-free)
Access code: 239 971 88700

Partner News and Announcements

11th Annual Symposium on Global Cancer Research

Read more about 11th Annual Symposium on Global Cancer Research

April 4, 2023 9:00 AM (EDT) - April 6, 2023 12:00 PM (EDT)

https://events.cancer.gov/cgh/asgcr

The 11th Annual Symposium on Global Cancer Research (ASGCR) will be held virtually April 4, 2023 – April 6, 2023 as a satellite meeting to the 14th Annual Consortium of Universities for Global Health (CUGH) Global Health Conference. The Symposium is organized through a collaboration with the US National Cancer Institute Center for Global Health; CUGH; the American Society of Clinical Oncology (ASCO); the American Association for Cancer Research (AACR); the African Organisation for Research and Training in Cancer (AORTIC); the American Society of Preventive Oncology (ASPO); and Red de Institutos e Instituciones Nacionales de Cáncer – Sociedad Latino Americana y del Caribe De Oncología Médica (RINC-SLACOM).

The theme of the 11th ASGCR is “Closing the Research-to-Implementation Gap” and the objectives of this virtual Symposium are to: (1) provide a venue for the global oncology research community to exchange information and identify potential areas for collaboration; (2) develop strategic priorities for advancing the field of global oncology; (3) share initiatives that are reducing the burden of cancer in low resource settings; and 4) create opportunities for researchers and program implementers from low resource settings to present their work.

Conference/Meeting

American Institute for Cancer Research conference on Diet, Obesity, Physical Activity and Cancer

Read more about American Institute for Cancer Research conference on Diet, Obesity, Physical Activity and Cancer

October 31, 2022 5:00 AM (EDT) - November 2, 2022 7:00 AM (EDT)

Lansdowne Resort and Spa Leesburg, Virginia & Online

The American Institute for Cancer Research (AICR) Research Conference is a unique forum that brings together researchers, clinicians and policy professionals dedicated to increasing knowledge, stimulating research and promoting cancer prevention and survivorship through diet, physical activity and weight management.

Find out more at: https://www.aicr.org/research/aicr-research-conference/

Contact for further information:

research@aicr.org

202-600-3004

Conference/Meeting

PaCCSC & CST Annual Research Forum 2022 | Clinical trials: new priorities

Read more about PaCCSC & CST Annual Research Forum 2022 | Clinical trials: new priorities

March 17, 2022 8:00 AM (EDT) - March 18, 2022 10:00 AM (EDT)

Virtual

The PaCCSC/CST Annual Research Forum is holding it's Annual Scientific Meeting on 17 & 18 March in Australia and will be of interest to those involved in Patient/Consumer engagement.

The session on Diversity, Access, and Inclusion in Clinical Trials includes Dr Amanda Landers in conversation with Michelle Stewart, CEO of PanKind, the pancreatic cancer advocacy agency in Australia discussing "Treatment trials vs supportive care trials - what's important to consumers"

Further details at:

https://www.uts.edu.au/research-and-teaching/our-research/impacct/paccs…

Conference/Meeting

AIRC Lecture: CAR-T: Changing the Treatment Paradigm for Aggressive Lymphoma

Read more about AIRC Lecture: CAR-T: Changing the Treatment Paradigm for Aggressive Lymphoma

April 8, 2022 11:00 AM (EDT) - April 8, 2022 12:00 PM (EDT)

Virtual

The lecture “CAR-T: Changing the Treatment Paradigm for Aggressive Lymphoma” will be given by Prof. David G. Maloney, MD, PhD (Professor, Clinical Research Division, Fred Hutchinson Cancer Research Center - University of Washington, Seattle, Washington, USA) April 8th 2022 at 5.00 pm Italian time.

For more information and to register visit: http://scienceseminars.airc.it/it/next-events.html

Conference/Meeting

10th Annual Symposium on Global Cancer Research (ASGCR)

Read more about 10th Annual Symposium on Global Cancer Research (ASGCR)

March 23, 2022 10:00 AM (EDT) - March 24, 2022 12:00 PM (EDT)

Virtual

In an effort to support innovative, impactful research that addresses key scientific issues in global cancer control, NCI-CGH will convene the 10th Annual Symposium on Global Cancer Research (ASGCR) as a virtual satellite meeting to the 13th annual conference of the Consortium of Universities for Global Health (CUGH). The Symposium will take place Wednesday, March 23 – Thursday, March 24, 2022, in partnership with CUGH, USC Norris Comprehensive Cancer Center, UCLA Jonsson Comprehensive Cancer Center, City of Hope Comprehensive Cancer Center, University Teaching Hospital, Ministry of Health, Republic of Zambia, Partners in Hope, Lilongwe, Malawi, Fundación Instituto Leloir-CONICET, Buenos Aires, Argentina, American Society of Clinical Oncology, and the American Association for Cancer Research.

This year's ASGCR will also include a pre-conference Early Career Investigator Day on Tuesday, March 22, 2022.

Conference/Meeting

Partner Virtual Meeting - March 2022

Read more about Partner Virtual Meeting - March 2022

March 17, 2022 6:00 PM (EDT) - March 17, 2022 7:00 PM (EDT)

Webex, online

ICRP March 2022 Partner Meeting

https://icrp.webex.com/icrp/j.php?MTID=m40c844325b0ca2c12e4aaf4898ad2b55
Thursday, Mar 17, 2022 10:00 pm | 1 hour | (UTC+00:00) Dublin, Edinburgh, Lisbon, London
Meeting number: 137 313 3501
Password: 4321

Join by video system
Dial 1373133501@icrp.webex.com
You can also dial 62.109.219.4 and enter your meeting number.

Join by phone
0800-051-3810 Call-in toll-free number (UK)
+44-203-478-5289 Call-in toll number (UK)
Access code: 137 313 3501

Annual Meetings

Partner Virtual Meeting - February 2022

Read more about Partner Virtual Meeting - February 2022

February 17, 2022 11:00 AM (EST) - February 17, 2022 12:00 PM (EST)

Webex, online

ICRP Feb 2022 Partner Meeting

https://icrp.webex.com/icrp/j.php?MTID=m410d9c983662ca04ea95a96f2ed40418
Thursday, Feb 17, 2022 4:00 pm | 1 hour | (UTC+00:00) Dublin, Edinburgh, Lisbon, London
Meeting number: 137 574 7449
Password: 4321

Join by video system
Dial 1375747449@icrp.webex.com
You can also dial 62.109.219.4 and enter your meeting number.

Join by phone
0800-051-3810 Call-in toll-free number (UK)
+44-203-478-5289 Call-in toll number (UK)
Access code: 137 574 7449

Annual Meetings

Subscribe to

Single-funder organizations
Partner	Caveat
ACS	Dollar amounts found in the ICRP database are different than what is reported in the American Cancer Society's Annual Report. The dollar amounts spent on research reported in audited reports include operating expenses of the Research Department. Additionally, the dollar amounts also exclude all grants that were cancelled after being awarded, but include money that was returned from grants cancelled in the current year that were awarded in previous years. The dollar amounts reported in the database are unaudited and include grants awarded each fiscal year, exclusive of grants that cancelled before activation.
CBCRP	The California Breast Cancer Research Program grants are awarded only to individuals or institutions in California. Grants to the University of California receive only direct funds, while grants to other institutions also receive indirect costs (overhead) at 25% or the federally negotiated rate. Collaborative awards are counted in graphs and tables by the number of co-Principal Investigators rather than the number of projects.
Komen	Dollar amounts found in the ICRP database are different than what is reported on Komen\'s website or in Komen\'s Annual Report for the following reasons: Komen commits all funds necessary to support a research grant in the year it is awarded. Therefore, Komen\'s website reports on the full amount of each grant in the year it is initiated, while the ICRP data is annualized, as described. Komen funds research grants to our Scientific Advisors (Scientific Advisory Board members and Komen Scholars) and also provides discretionary funding of research-related projects that are not traditional research grants (e.g. support of the Komen Tissue Bank, ASCO and AACR meeting support). These are included in the overall Research Program spending, as reported in our Annual Report and on our website, but are not included in the ICRP database.
NIH	NIH projects in NIH Reporter assigned to the Spend Category ‘cancer’ are included in the ICRP database from FY2005 onwards. A small number of projects are excluded if essential information is missing (primarily Project title, Institution). Previous years’ data were drawn from the NFRP and may be incomplete. Starting in FY2007 NCI reports funding supplements, etc., for each grant separately instead of including them in the main project, therefore the number of projects may differ significantly from those of previous years. Projects with a cost of $0 include those that were a no-cost extension of the grant or when funding was provided by another NIH institute or center for that FY. NCI dollars in the ICRP database are drawn from NIH reporter and may not match dollars from other NCI-only databases.
Worldwide Cancer Research	Worldwide Cancer Research is unique in that the majority of our funding is awarded to researchers in countries outside the UK. Like many UK research charities, Worldwide Cancer Research only funds the direct costs of research. This creates significant problems in making quantitative comparisons between our funding and that provided by some of the other agencies in the ICRP, which fund both the direct and indirect costs (often called overheads) of research.

UK Organizations that are part of NCRI
Partner	Caveat
NCRI (GENERIC)	NCRI submits data to ICRP on behalf of all UK NCRI members from its Cancer Research Database (CaRD). The database only includes entries where funding can be directly attributed to a set of clearly defined research objectives. This means that the CaRD only contains information on all direct research funding (project, programme, fellowship, unit and institute) financed by NCRI Member organizations, for which an abstract has been submitted and where the project is active in any given financial year (April - March). Examples of funding that are currently outside the scope of CaRD are infrastructure, meeting grants and research management support."
Breakthrough (UK)	The ICRP database includes all Breakthrough Breast Cancer\'s research spend reported through its Annual Reports & Accounts. There is some variance due to different reporting periods (1 April snapshot versus full financial year) meaning that some research spend that is already committed may not be included in the ICRP figures. Expenditure on non-research charitable activities and management support costs are excluded from the NCRI, and by extension, the ICRP dataset. For further information on Breakthrough\'s research please visit www.breakthroughresearch.org.uk or email research@breakthrough.org.uk
CR-UK (UK)	The ICRP database includes around 70% of Cancer Research UK\'s direct research spend per financial year as reported through its Annual Reports & Accounts. There is some variance due to different reporting periods meaning that some direct research spend that is planned for allocation will not be included in the ICRP figures. Expenditure on vital research services, technology transfer, meeting grants, research management support and infrastructure to support Cancer Research UK\'s activities is excluded from the NCRI, and by extension, the ICRP dataset.
Department of Health (UK)	There will always be some variance between the figures available on ICRP and the figures reported publicly by DH. There are two reasons for this. Firstly, there is variance due to different reporting periods (1 April snapshot of ICRP versus full financial year reporting by DH). Secondly, the Department\'s National Institute for Health Research (NIHR) encompasses various expenditure on NHS infrastructure for research relevant to cancer that is not in a format that it is possible to capture for ICRP.
Macmillan (UK)	The ICRP database represents about 90% of Macmillan Cancer Support\'s direct research spend per financial year. There is some variance due to different reporting periods meaning that some direct research spend that is planned for allocation will not be included in the ICRP figures. Expenditure on research management support and infrastructure to support Macmillan Cancer Support\'s activities is excluded from the NCRI, and by extension, the ICRP dataset.
Scottish Government Health Directorates (UK)	Scottish Government is committed to improve the health of the Scottish population and the Chief Scientist\'s Office (CSO) funds across a broad range of relevant disease areas. Overall, 75% of the CSO spend is committed to research infrastructure in NHS Scotland. This and much other research expenditure is therefore outside the NCRI remit and, by extension, the ICRP dataset.

Canadian organizations who are part of the CCRA
Partner	Caveat
CCRA	Caveats/limitations specific to Canadian Cancer Research Alliance organizations can be accessed here.

Difference	Detail	Impact on investment figures
Not all CCRS participating organizations are included in the ICRP.	For the period 2005–2021, CCRA submitted data to the ICRP for 35 organizations and three now defunct multi-funded initiatives (CBCRA, CPCRI, and CTCRI). Note that the Canadian Breast Cancer Research Foundation merged operations with the Canadian Cancer Society in February 2017 and Prostate Cancer Canada merged in 2020. Importantly, Alberta Innovates did not report any research projects for 2020 and 2021 due to staffing constraints. Projects within the CCRS total 30,218, of which 24,129 were reported to ICRP.	Moderate for years 2020 and 2021
Not all CCRS projects are included in the ICRP.	“Related support” grants (i.e., travel awards, workshops/symposia, LOIs, etc.) are not submitted to ICRP, but are included in reports released by CCRA. In addition, equipment/infrastructure grants through the Canada Foundation for Innovation and for other funders where the cancer relevance weighting is less than 80% are not reported to the ICRP, but are included in CCRA reports. Any project with cancer relevance of less than 20% is also not reported to the ICRP.	Moderate
Co-funded projects are listed by the administering organization.	Projects that are co-funded appear under the administering organization and are not duplicated per funder. Within CCRA reports, however, investments are reported by the actual funders.	Minor
ICRP uses a different approach to calculating annual project investment.	CCRA provides ICRP with the project budget (adjusted for cancer relevance) and start and end dates. A pro-rated calculation is used to derive annual investment. Within the CCRS, prorated calculations on the basis of annual project amounts (where those data are available) are used to calculate the annual investment.	Minor
ICRP uses different site coding conventions.	The cancer site/type codes used within the CCRS are different from ICRP site codes so results by site will vary in some instances.	Minor
ICRP has technical limitations.	ICRP has a technical limit of 12 site codes and 8 CSO codes and this requires truncation for a couple of large-scale projects within the CCRS.	Very minor
CCRA provides less descriptive information about its projects to ICRP.	Lay abstracts are submitted by CCRA to the ICRP in lieu of technical abstracts and in their language of origin. For projects without lay abstracts (and there are a significant number of these), only titles are provided. An English translation is provided alongside all French project titles to facilitate use of the search engine.	No impact on investment figures, but limits full functionality of search engine especially for organizations that do not collect/report lay abstracts.